Halozyme Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HALO research report →
About the company
Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20).
- CEO
- Helen I. Torley
- IPO
- 2004
- Employees
- 350
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $9.42B
- P/E
- 27.21
- P/S
- 6.25
- P/B
- 42.74
- EV/EBITDA
- 18.05
- Div Yield
- 0.00%
- Gross Margin
- 76.93%
- Op Margin
- 56.96%
- Net Margin
- 23.13%
- ROE
- 126.27%
- ROIC
- 23.65%
- Revenue
- $1.40B · 37.55%
- Net Income
- $316.89M · -28.64%
- EPS
- $2.64 · -24.57%
- Op Income
- $816.29M
- FCF YoY
- 37.62%
- 52W High
- $82.22
- 52W Low
- $53.65
- 50D MA
- $69.02
- 200D MA
- $69.11
- Beta
- 0.87
- Avg Volume
- 1.72M
Get TickerSpark's AI analysis on HALO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | RAMSAY DAVID A | other | 39,823 |
| Jul 1, 26 | RAMSAY DAVID A | other | 16,232 |
| Jun 30, 26 | RAMSAY DAVID A | other | 10,000 |
| Jun 30, 26 | RAMSAY DAVID A | other | 5,408 |
| Jun 30, 26 | RAMSAY DAVID A | other | 10,000 |
| Jul 1, 26 | Snellgrove Darren | other | 127,432 |
| Jul 1, 26 | Snellgrove Darren | other | 41,554 |
| Jul 1, 26 | Connaughton Bernadette | sell | 1,000 |
| Jul 1, 26 | Connaughton Bernadette | sell | 625 |
| Jun 29, 26 | Krishnan Mahesh | other | 7,304 |
Our HALO coverage
Recent articles, reports, and earnings notes.
No research on HALO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HALO report →Similar companies
Peers in the same neighborhood.